These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 13679677)

  • 1. Polyunsaturated fatty acids, thrombosis and vascular disease.
    Di Minno G; Tufano A; Garofano T; Di Minno MN
    Pathophysiol Haemost Thromb; 2002; 32(5-6):361-4. PubMed ID: 13679677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrition and thrombogenic factors.
    Di Minno G; Piemontino U; Cerbone AM
    Nutr Metab Cardiovasc Dis; 1999 Aug; 9(4 Suppl):16-20. PubMed ID: 10715834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Maggioni AP; Marfisi RM; Silletta MG; Tavazzi L; Tognoni G; Valagussa F;
    J Membr Biol; 2005 Jul; 206(2):117-28. PubMed ID: 16456722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Omega-3 polyunsaturated fatty acids and cardiovascular diseases].
    Marchioli R
    Minerva Cardioangiol; 2003 Oct; 51(5):561-76. PubMed ID: 14551524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial.
    Singer P; Wirth M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):153-9. PubMed ID: 15253884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
    Christensen JH
    Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
    Verboom CN;
    Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio (GISSI)-Prevenzione Trial on fish oil and vitamin E supplementation in myocardial infarction survivors.
    Stone NJ
    Curr Cardiol Rep; 2000 Sep; 2(5):445-51. PubMed ID: 10980913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats.
    Zeghichi-Hamri S; de Lorgeril M; Salen P; Chibane M; de Leiris J; Boucher F; Laporte F
    Nutr Res; 2010 Dec; 30(12):849-57. PubMed ID: 21147368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
    Lancet; 1999 Aug; 354(9177):447-55. PubMed ID: 10465168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
    Yokoyama M; Origasa H;
    Am Heart J; 2003 Oct; 146(4):613-20. PubMed ID: 14564313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
    Marchioli R; Marfisi RM; Borrelli G; Chieffo C; Franzosi MG; Levantesi G; Maggioni AP; Nicolosi GL; Scarano M; Silletta MG; Schweiger C; Tavazzi L; Tognoni G
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S34-7. PubMed ID: 17876196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men.
    Mozaffarian D; Ascherio A; Hu FB; Stampfer MJ; Willett WC; Siscovick DS; Rimm EB
    Circulation; 2005 Jan; 111(2):157-64. PubMed ID: 15630029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart and nutrition: which fatty acids for which cardiac function?].
    Grynberg A
    Arch Mal Coeur Vaiss; 2003 Sep; 96 Spec No 6():7-12. PubMed ID: 14655544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality.
    Masson S; Marchioli R; Mozaffarian D; Bernasconi R; Milani V; Dragani L; Tacconi M; Marfisi RM; Borgese L; Cirrincione V; Febo O; Nicolis E; Maggioni AP; Tognoni G; Tavazzi L; Latini R
    Am Heart J; 2013 Feb; 165(2):208-15.e4. PubMed ID: 23351824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: a review.
    Valk EE; Hornstra G
    Int J Vitam Nutr Res; 2000 Mar; 70(2):31-42. PubMed ID: 10804454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention.
    Russo GL
    Biochem Pharmacol; 2009 Mar; 77(6):937-46. PubMed ID: 19022225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and coronary heart disease.
    Oliver MF
    Hum Nutr Clin Nutr; 1982; 36(6):413-27. PubMed ID: 6298152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
    Rupp H; Wagner D; Rupp T; Schulte LM; Maisch B
    Herz; 2004 Nov; 29(7):673-85. PubMed ID: 15580322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.